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Clinical PerspectiveWhat Is New?Our study results suggest impaired global longitudinal strain relates to worse episodic memory and language performance among older adults who are free of clinical dementia, stroke, and heart failure, and such subclinical cardiac dysfunction may affect cerebral blood flow homeostasis, resulting in oligemia and compromised cognitive functions mediated by the temporal lobes in the brain.What Are the Clinical Implications?Understanding the association between subclinical cardiac dysfunction and cognitive impairment may allow for earlier detection and intervention to prevent more serious cognitive changes associated with compromised cardiovascular health.

 {#jah32936-sec-0008}

Severe cardiac dysfunction, as measured by left ventricular ejection fraction (LVEF), is associated with cognitive impairment.[1](#jah32936-bib-0001){ref-type="ref"}, [2](#jah32936-bib-0002){ref-type="ref"} However, reduced LVEF represents a mid to late feature of impaired myocardial contractility[3](#jah32936-bib-0003){ref-type="ref"} and is normal in 50% of individuals with clinical heart failure.[4](#jah32936-bib-0004){ref-type="ref"} Emerging evidence suggests an association between subclinical heart dysfunction and worse brain health in older adults,[5](#jah32936-bib-0005){ref-type="ref"} but LVEF may not detect subclinical dysfunction[6](#jah32936-bib-0006){ref-type="ref"} or relate to cognitive changes in the absence of severe cardiac dysfunction.

In recent years, cardiac strain has emerged as a more sensitive measure of myocardial function. Global longitudinal strain (GLS) assesses the total deformation or shortening during the cardiac cycle of longitudinal myocardial fibers located predominantly in the subendocardium.[7](#jah32936-bib-0007){ref-type="ref"} Because the subendocardium is the layer most susceptible to ischemia,[7](#jah32936-bib-0007){ref-type="ref"} GLS may provide a more accurate measure of cardiac contractility[6](#jah32936-bib-0006){ref-type="ref"} or subclinical heart disease[8](#jah32936-bib-0008){ref-type="ref"} even when LVEF is normal. GLS has also been shown to have prognostic value in identifying cardiac dysfunction independent[9](#jah32936-bib-0009){ref-type="ref"} of and additive[10](#jah32936-bib-0010){ref-type="ref"} to LVEF. Thus, GLS may be more sensitive in detecting an association between subclinical cardiac dysfunction and cognition in comparison to LVEF. In a prior study, worse GLS was associated with increased cerebral small vessel disease among older adults without prevalent cardiovascular disease (CVD).[6](#jah32936-bib-0006){ref-type="ref"} However, cardiac strain has not been thoroughly evaluated in relation to cognition among aging adults who endure decades of vascular risk factor exposure.[11](#jah32936-bib-0011){ref-type="ref"}, [12](#jah32936-bib-0012){ref-type="ref"}

The purpose of this cross‐sectional study was to examine subclinical cardiac dysfunction, assessed by GLS and LVEF, in relation to neuropsychological performance among older adults without clinical dementia, stroke, or heart failure. We hypothesized that GLS would relate to cognition, especially memory[13](#jah32936-bib-0013){ref-type="ref"}, [14](#jah32936-bib-0014){ref-type="ref"} and executive function,[15](#jah32936-bib-0015){ref-type="ref"}, [16](#jah32936-bib-0016){ref-type="ref"} known to be most affected by compromised cardiovascular function. We also hypothesized that GLS would have stronger associations with cognition than LVEF.

Methods {#jah32936-sec-0009}
=======

Study Cohort {#jah32936-sec-0010}
------------

The Vanderbilt Memory and Aging Project is a longitudinal study investigating vascular health and brain aging, enriched for mild cognitive impairment (MCI). Inclusion required participants be aged ≥60 years, speak English, have adequate auditory and visual acuity, and have a reliable study partner. At eligibility, participants underwent medical history and record review, a clinical interview (including a functional questionnaire and Clinical Dementia Rating[17](#jah32936-bib-0017){ref-type="ref"} with the informant), and neuropsychological assessment. Participants were excluded for a cognitive diagnosis other than normal cognition (NC), early MCI,[18](#jah32936-bib-0018){ref-type="ref"} or MCI[19](#jah32936-bib-0019){ref-type="ref"}; contraindication to magnetic resonance imaging; history of neurological disease (eg, stroke); prevalent heart failure; major psychiatric illness; head injury with loss of consciousness \>5 minutes; and systemic or terminal illness affecting follow‐up examination participation. At enrollment, participants completed a comprehensive evaluation, including (but not limited to) fasting blood draw, physical examination, a clinical interview, medication review, neuropsychological assessment, and cardiac magnetic resonance (CMR) imaging. Participants were excluded from the current study for missing CMR, covariate, or neuropsychological data (see Figure [1](#jah32936-fig-0001){ref-type="fig"} for inclusion and exclusion details).

![Participant inclusion and exclusion details. Missing data categories are mutually exclusive. In secondary models, sensitivity analyses excluded participants with CVD or atrial fibrillation. CMR indicates cardiac magnetic resonance; CVD, cardiovascular disease; GLS, global longitudinal strain; LVEF, left ventricular ejection fraction.](JAH3-7-e007562-g001){#jah32936-fig-0001}

Standard Protocol Approvals, Registrations, and Participant Consent {#jah32936-sec-0011}
-------------------------------------------------------------------

The protocol was approved by the Vanderbilt University Medical Center institutional review board. Written informed consent was obtained before data collection. The data, analytic methods, and study materials are unavailable to other researchers for purposes of reproducing the results or replicating procedures because of participant consent restrictions on data sharing.

CMR Imaging {#jah32936-sec-0012}
-----------

CMR imaging was acquired at Vanderbilt University Medical Center using a 1.5‐T Siemens Avanto system with a phased‐array torso receiver coil. Left and right ventricular volumes and function were assessed using a breath‐hold, ECG‐synchronized, cine steady‐state free precession sequence with the following parameters: repetition time, 180 ms; echo time, 1.1 ms; flip angle, 80°; field of view, 300 to 340 mm; and 156×192 matrix. Short‐ and long‐axis imaging planes were acquired. Under the supervision of a board‐certified radiologist (J.J.C.), trained analysts blinded to all clinical information (J.G.T., S.N.) drew endocardial and epicardial contours at end systole and end diastole to quantify left ventricular (LV) volume and function using QMass MR 7.6 Enterprise Solution (Medis). Ejection fraction (percentage) was calculated as stroke volume divided by end‐diastolic volume multiplied by 100. Longitudinal strain was assessed for systole using QStrain RE 2.0 (Medis). A trained analyst drew contours in a semiautomated manner in the 4‐ and 2‐chamber long‐axis images in QMass (Medis). These contours, along with LV epicardial and endocardial contours drawn in QMass were imported into QStrain. Base, middle, and apical slices were iteratively selected in a manual fashion for automated analyses. At each step, the analyst reviewed image clips generated in QStrain to ensure that tracking curves and vectors were correct and that selected images yielded accurate results. Strain results were determined per cardiac segment using the 17‐segment model and averaged to yield a global value for the longitudinal strain orientation. GLS is represented by a negative value to measure the shortening of the myocardium during the cardiac cycle as a percentage of its original length. Lower (ie, more negative) values indicate increased systolic shortening and thus better function.

Neuropsychological Assessment {#jah32936-sec-0013}
-----------------------------

Participants completed a common, comprehensive neuropsychological protocol assessing language, information processing speed, executive functioning, visuospatial skills, and episodic memory (see Table [1](#jah32936-tbl-0001){ref-type="table-wrap"} for details). Measures were carefully selected to preclude floor or ceiling effects and were not used to screen or select participants into the study.

###### 

Participant Characteristics

                                                                                   Total (n=318)   NC (n=166)   eMCI (n=27)   MCI (n=125)
  -------------------------------------------------------------------------------- --------------- ------------ ------------- -------------
  Demographic and health characteristics                                                                                      
  Age, y                                                                           73±7            72±7         73±6          73±8
  Sex, % male                                                                      58              58           74            55
  Race, % non‐Hispanic white                                                       87              88           85            86
  Education, y                                                                     16±3            16±2         16±3          15±3
  Montreal Cognitive Assessment, total                                             25±3            27±2         25±2          23±3
  *APOE\*ε4* % carrier                                                             34              29           22            44
  Framingham Stroke Risk Profile, total[a](#jah32936-note-0004){ref-type="fn"}     12.3±4.2        11.7±4.1     13.4±3.2      12.8±4.3
  Systolic blood pressure, mm Hg                                                   142±18          140±17       150±18        145±19
  Antihypertensive medication usage, %                                             53              52           56            54
  Diabetes mellitus, %                                                             18              14           22            22
  Cigarette smoking, % current                                                     2               1            4             2
  Prevalent CVD, %                                                                 3               4            0             3
  Atrial fibrillation, %                                                           5               5            11            5
  LV hypertrophy, %                                                                4               2            4             6
  Global longitudinal strain, %                                                    −21.6±4.5       −21.9±4.7    −21.0±4.9     −21.4±4.2
  LVEF, %                                                                          63.5±7.8        64.0±7.4     63.0±10.0     63.0±7.9
  Neuropsychological performances                                                                                             
  Boston Naming Test                                                               26.8±3.1        27.9±2.0     26.6±2.4      25.3±3.8
  Animal Naming                                                                    18.9±5.4        20.9±4.8     19.4±3.4      16.20±5.2
  WAIS‐IV Coding                                                                   52.7±12.8       57.5±11.5    53.4±11.2     46.3±12.1
  D‐KEFS Number Sequencing Test, s[b](#jah32936-note-0005){ref-type="fn"}          42.0±18.9       35.9±12.6    42.0±13.2     50.3±23.4
  Executive Function composite score                                               0.01±0.90       0.43±0.62    0.17±0.42     −0.59±0.96
  D‐KEFS Number--Letter Switching Test, s[b](#jah32936-note-0005){ref-type="fn"}   107.3±48.3      86.5±34.1    93.0±22.1     138.3±52.3
  D‐KEFS Tower Test                                                                14.97±4.66      16.13±4.34   16.19±3.53    13.16±4.74
  D‐KEFS Color--Word Inhibition Test, s[b](#jah32936-note-0005){ref-type="fn"}     69.2±23.5       60.0±13.5    74.6±15.5     80.0±29.6
  Letter Fluency (FAS) Test                                                        38.7±11.6       42.9±11.4    37.9±11.1     33.3±9.7
  Hooper Visual Organization Test                                                  24.5±3.1        25.4±2.5     24.7±2.2      23.3±3.6
  Memory composite score                                                           0.01±0.95       0.57±0.70    −0.06±0.76    −0.72±0.75
  CVLT‐II Total Immediate Recall                                                   40.6±11.8       47.1±9.3     40.1±9.7      32.2±9.6
  CVLT‐II Delayed Recall                                                           8.1±4.2         10.5±3.3     7.6±3.5       5.1±3.4
  CVLT‐II Recognition                                                              2.4±1.0         3.0±0.7      2.3±0.8       1.7±0.9
  BFLT Total Immediate Recall                                                      112.7±40.7      136.1±29.5   110.0±28.0    82.0±35.0
  BFLT Delayed Recall                                                              27.0±10.4       32.6±7.5     28.0±6.6      19.4±9.7
  BLFT Recognition                                                                 0.7±0.2         0.8±0.2      0.7±0.2       0.6±0.2

Values denoted as mean±SD or frequency; all neuropsychological performance values are total correct excluding timed tasks measured in seconds. The Boston Naming Test was the 30‐item odd version. *APOE\*ε4* indicates apolipoprotein E ε4 allele; BFLT, Biber Figure Learning Test; CVD, cardiovascular disease; CVLT‐II, California Verbal Learning Test, Second Edition; D‐KEFS, Delis--Kaplan Executive Function System; eMCI, early mild cognitive impairment; LV, left ventricular; LVEF, left ventricular ejection fraction; MCI, mild cognitive impairment; NC, normal cognition; WAIS‐IV, Wechsler Adult Intelligence Scale, Fourth Edition.

A modified Framingham Stroke Risk Profile Score was included in statistical models, which excluded points assigned to age (total 6.4±3.0, NC 6.0±2.9, eMCI 7.4±2.6, MCI 6.8±3.3).

Higher values in speeded test results indicate worse performance.

Statistical Analyses {#jah32936-sec-0014}
--------------------

Systolic blood pressure was the mean of 2 measurements. Diabetes mellitus was defined as fasting blood glucose ≥126 mg/dL, hemoglobin A1c ≥6.5%, or oral hypoglycemic or insulin medication usage. Medication review determined antihypertensive medication use. LV hypertrophy was defined on echocardiogram (LV mass index \>115 g/m^2^ in men, \>95 g/m^2^ in women). Self‐report atrial fibrillation was corroborated by any one of the following sources: echocardiogram, documented prior procedure or ablation for atrial fibrillation, CMR, or medication usage for atrial fibrillation. Current cigarette smoking (yes or no within the year before baseline) was ascertained by self‐report. Self‐reported prevalent CVD with supporting medical record evidence included coronary heart disease, angina, or myocardial infarction (note, heart failure was a parent‐study exclusion). Framingham Stroke Risk Profile (FSRP) score was calculated by applying points by sex for age, systolic blood pressure accounting for antihypertensive medication usage, diabetes mellitus, current cigarette smoking, LV hypertrophy, CVD, and atrial fibrillation. *APOE* (apolipoprotein E) genotyping was performed on whole blood samples. *APOE* ε4 (*APOE\*ε4*) carrier status was defined as positive (ε2/ε4, ε3/ε4, ε4/ε4) or negative (ε2/ε2, ε2/ε3, ε3/ε3).[20](#jah32936-bib-0020){ref-type="ref"}

To minimize multiple comparisons, 2 cognitive composites were calculated using previously published methodology.[21](#jah32936-bib-0021){ref-type="ref"} First, a memory composite was calculated leveraging item‐level data from the California Verbal Learning Test, Second Edition (CVLT‐II) and the Biber Figure Learning Test (BFLT). Briefly, a bifactor latent variable model was calculated in Mplus (version 7.4, <https://www.statmodel.com/>) in which each indicator was treated as a continuous variable and loaded on both a general factor and a test factor (CVLT‐II or BFLT to remove nuisance test effects). For both tests, the model included Trials 1 to 5 Total Learning, Immediate Recall, Delayed Recall, and Recognition. The memory composite model fit the data well (ie, root mean square error of approximation: 0.09; comparative fit index: 0.95; Tucker‐Lewis Index: 0.94) and is graphically summarized in Figure [S1](#jah32936-sup-0001){ref-type="supplementary-material"}. Next, an executive function composite was calculated leveraging item‐level data from the Delis--Kaplan Executive Function System (D‐KEFS) Color--Word Inhibition Test, D‐KEFS Tower Test, Letter Fluency (FAS) Test, and D‐KEFS Letter--Number Switching Test in which each indicator was treated as a continuous variable. The executive function composite model also fit the data well (ie, root mean square error of approximation: 0.03; comparative fit index: 0.99; Tucker‐Lewis Index: 0.99) and is graphically summarized in Figure [S2](#jah32936-sup-0001){ref-type="supplementary-material"}. The final composite scores represent *z* scores.

For hypothesis testing, linear regression models with ordinary least square estimates related GLS to cross‐sectional neuropsychological test performances (1 outcome per model). Models were repeated using LVEF as the predictor. All models were adjusted for age, sex, race/ethnicity, education, modified FSRP (excluding points assigned for age), *APOE\*ε4*, and cognitive diagnosis. Sensitivity analyses were performed excluding participants with atrial fibrillation and prevalent CVD. Models were repeated with cognitive diagnosis (NC, MCI) as an interaction term (excluding participants with early MCI because of small sample size). To formally test whether GLS had stronger associations with cognition than LVEF, a bootstrapping approach was applied to statistically compare the variance in each statistically significant outcome explained by GLS with the variance explained by LVEF using Spearman semipartial correlation. Significance was set a priori at *P*\<0.05. Analyses were conducted using R 3.3.2 (<https://www.r-project.org>). Post hoc power calculations were conducted using an F distribution based on increased *R* ^2^ in a main effect model that included the predictor plus covariates for each outcome (ie, squared semipartial correlation between the predictor and outcome adjusting for covariates). Based on the available sample size (n=318) and type I error of 0.05, the power to detect the increased *R* ^2^ for each predictor--outcome pair consistently exceeded 90, suggesting models were sufficiently powered to detect effects between GLS or LVEF and each cognitive outcome of interest.

Results {#jah32936-sec-0015}
=======

Participant Characteristics {#jah32936-sec-0016}
---------------------------

Participants included 318 adults aged 60 to 92 years (73±7 years), 58% were men, and 87% self‐identified as non‐Hispanic white. GLS ranged from −35.5% to −10.7%. LVEF ranged from 27.0% to 83.1%. See Table [1](#jah32936-tbl-0001){ref-type="table-wrap"} for sample characteristics.

GLS and Neuropsychological Performances {#jah32936-sec-0017}
---------------------------------------

Compromised GLS (reflected by higher values) related to worse Boston Naming Test performance (β=−0.07, *P*=0.04; see Figure [2](#jah32936-fig-0002){ref-type="fig"}A) and episodic memory composite score (β=−0.02, *P*=0.04, see Figure [2](#jah32936-fig-0002){ref-type="fig"}B). In secondary models examining the individual indices comprising the memory composite, compromised GLS related to worse BFLT Immediate Recall (β=−0.83, *P*=0.03; see Figure [2](#jah32936-fig-0002){ref-type="fig"}C), BFLT Delayed Recall (β=−0.22, *P*=0.03; see Figure [2](#jah32936-fig-0002){ref-type="fig"}D), and CVLT‐II Delayed Recall performances (β=−0.11, *P*=0.007; see Figure [2](#jah32936-fig-0002){ref-type="fig"}E). GLS was unrelated to all remaining measures (*P*\>0.05; Table [2](#jah32936-tbl-0002){ref-type="table-wrap"}). In sensitivity analyses excluding participants with prevalent CVD or atrial fibrillation, GLS remained associated with Boston Naming Test (β=−0.08, *P*=0.046), CVLT‐II Delayed Recall (β=−0.10, *P*=0.02), and BFLT Immediate Recall (β=−0.81, *P*=0.046) performance. All remaining associations were attenuated (*P*\>0.05), including the episodic memory composite (*P*=0.10). Among the entire sample, the GLS×cognitive diagnosis interaction term was unrelated to all neuropsychological performances (*P*\>0.19).

![GLS and neuropsychological outcomes. Solid black line reflects fitted (predicted) values of cognitive outcomes (*y*‐axis) corresponding to cardiac strain (*x*‐axis) for a given participant profile (using prevalent level for categorical variables and median for continuous variables). Shading reflects 95% confidence interval. A, GLS and Boston Naming Test. B, GLS and memory composite. C, GLS and BFLT Immediate Recall, total. D, GLS and BFLT Delayed Recall, total. E, GLS and CVLT‐II Delayed Recall, total. BFLT indicates Biber Figure Learning Test; CVLT‐II, California Verbal Learning Test, Second Edition; GLS, global longitudinal strain.](JAH3-7-e007562-g002){#jah32936-fig-0002}

###### 

Cardiac Dysfunction and Neuropsychological Performance

                                                                                   GLS      LVEF                                              
  -------------------------------------------------------------------------------- -------- ---------------- ------- -------- --------------- ------
  Boston Naming Test                                                               −0.07    −0.14, −0.002    0.04    −0.005   −0.04, 0.03     0.82
  Animal naming                                                                    −0.06    −0.17, 0.06      0.33    −0.008   −0.07, 0.06     0.81
  WAIS‐IV coding                                                                   0.003    −0.27, 0.28      0.98    −0.02    −0.17, 0.14     0.84
  D‐KEFS Number Sequencing Test, s[a](#jah32936-note-0008){ref-type="fn"}          −0.38    −0.80, 0.04      0.08    0.27     0.03, 0.50      0.02
  Executive composite                                                              −0.004   −0.02, 0.01      0.64    −0.003   −0.01, 0.007    0.57
  D‐KEFS Letter--Number Switching Test, s[a](#jah32936-note-0008){ref-type="fn"}   −0.006   −0.97, 0.96      0.99    0.30     −0.24, 0.83     0.27
  D‐KEFS Tower Test                                                                −0.05    −0.16, 0.06      0.37    0.006    −0.05, 0.07     0.85
  D‐KEFS Color--Word Inhibition Test, s[a](#jah32936-note-0008){ref-type="fn"}     0.23     −0.30, 0.76      0.39    −0.07    −0.37, 0.23     0.63
  Letter Fluency (FAS) Test                                                        −0.08    −0.34, 0.18      0.52    0.03     −0.11, 0.18     0.65
  Hooper Visual Organization Test                                                  −0.01    −0.09, 0.06      0.69    0.02     −0.02, 0.06     0.34
  Memory composite                                                                 −0.02    −0.03, −0.0005   0.04    0.006    −0.004, 0.02    0.26
  CVLT‐II total immediate recall                                                   −0.12    −0.35, 0.10      0.28    0.08     −0.04, 0.21     0.19
  CVLT‐II delayed recall                                                           −0.11    −0.19, 0.03      0.007   0.02     −0.03, 0.07     0.40
  CVLT‐II recognition                                                              −0.02    −0.04, 0.002     0.07    0.004    −0.007, 0.02    0.43
  BFLT total immediate recall                                                      −0.83    −1.59, −0.07     0.03    −0.04    −0.47, 0.39     0.86
  BFLT delayed recall                                                              −0.22    −0.42, −0.02     0.03    0.01     −0.10, 0.12     0.86
  BFLT recognition                                                                 −0.004   −0.009, 0.00     0.05    0.001    −0.001, 0.004   0.29

Analyses performed on n=318 participants. Models were adjusted for age, race/ethnicity, education, Framingham Stroke Risk Profile minus age, cognitive diagnosis, and APOE\*ε4 status; β indicates the change in outcome as a function of 1‐U increase in the raw value of the predictor; neuropsychological performance values are total correct excluding timed tasks measured in seconds. The Boston Naming Test was the 30‐item odd version. BFLT indicates Biber Figure Learning Test; CI, confidence interval; CVLT‐II, California Verbal Learning Test, Second Edition; D‐KEFS, Delis--Kaplan Executive Function System; GLS, global longitudinal strain; LVEF, left ventricular ejection fraction; WAIS‐IV, Wechsler Adult Intelligence Scale, Fourth Edition.

Higher values in speeded test results indicate worse performance.

LVEF and Neuropsychological Performances {#jah32936-sec-0018}
----------------------------------------

LVEF was unrelated to worse performance on any neuropsychological measure (*P*\>0.19; Table [2](#jah32936-tbl-0002){ref-type="table-wrap"}). However, higher (healthier) LVEF was related to slower (worse) Number Sequencing Performance (β=0.27, *P*=0.02), an observation that persisted in a model unadjusted for covariates (β=0.32, *P*=0.02) and in a fully adjusted model when participants with prevalent CVD or atrial fibrillation were excluded (β=0.26, *P*=0.051). Among the entire sample, the LVEF×cognitive diagnosis interaction term was not associated with any neuropsychological performances (*P*\>0.08).

Given the counterintuitive finding between LVEF and Number Sequencing performance, post hoc analyses explored potential interactions, all of which yielded null results, including LVEF×age (*P*=0.93), LVEF×sex (*P*=0.32), LVEF×cognitive diagnosis (*P*=0.66), LVEF×race/ethnicity (*P*=0.13), LVEF×education (*P*=0.25), LVEF×FSRP (*P*=0.46), and LVEF×*APOE\*ε4* (*P*=0.63). Despite null interaction models, stratified results suggested the counterintuitive finding was present in participants who were *APOE\*ε4* negative (β=0.23, *P*=0.05), were male (β=0.36, *P*=0.02), were younger (β=0.28, *P*=0.09), had less education (β=0.39, *P*=0.01), and had lower FSRP scores (excluding points assigned to age, β=0.35, *P*=0.03). However, all 3‐way interaction combinations were null (data not shown).

Statistical Comparisons of Effect Size Estimates for GLS and LVEF {#jah32936-sec-0019}
-----------------------------------------------------------------

Among the 6 significant cognitive outcomes, GLS was more strongly related to CVLT‐II Delayed Recall (*P*=0.04), BFLT Total Immediate Recall (*P*=0.008), and BFLT Delayed Recall (*P*=0.03) than LVEF. There was no difference in variance explained by GLS and LVEF for the remaining 3 measures. See Table [3](#jah32936-tbl-0003){ref-type="table-wrap"} for full semipartial correlation results.

###### 

Statistical Comparison of Effect Size Estimates

                                  Semipartial Correlation[a](#jah32936-note-0010){ref-type="fn"}   *P* Value   
  ------------------------------- ---------------------------------------------------------------- ----------- -------
  Boston Naming Test              −0.06                                                            −0.02       0.25
  D‐KEFS Number Sequencing Test   −0.01                                                            0.07        0.87
  Memory composite                −0.09                                                            0.05        0.15
  CVLT‐II Delayed Recall          −0.12                                                            0.04        0.04
  BFLT Total Immediate Recall     −0.12                                                            −0.003      0.008
  BFLT Delayed Recall             −0.10                                                            0.008       0.03

Analyses performed on n=318 participants. The Boston Naming Test was the 30‐item odd version. BFLT indicates Biber Figure Learning Test; CVLT‐II, California Verbal Learning Test, Second Edition; D‐KEFS, Delis--Kaplan Executive Function System; GLS, global longitudinal strain; LVEF, left ventricular ejection fraction.

Spearman semipartial correlations with models adjusted for age, race/ethnicity, education, Framingham Stroke Risk Profile minus age, and cognitive diagnosis.

Discussion {#jah32936-sec-0020}
==========

Among community‐dwelling older adults free of clinical dementia, stroke, and prevalent heart failure, compromised GLS related to worse episodic memory and language performance. Using comprehensive and sensitive CMR methods for quantifying cardiac function, associations were statistically independent of key covariates, including vascular risk factors, prevalent CVD, and atrial fibrillation. In contrast, LVEF was not related to worse performance on any cognitive measure.

Our study is among the first to use GLS as a measure of cardiac dysfunction in relation to cognition. Although LVEF is the most commonly used measure of cardiac function, it is load dependent, influenced by heart rate, and may not accurately reflect cardiac contractility as long as ventricular--vascular coupling is maintained[22](#jah32936-bib-0022){ref-type="ref"} or in the presence of hypertrophy.[23](#jah32936-bib-0023){ref-type="ref"}, [24](#jah32936-bib-0024){ref-type="ref"} GLS, however, has been shown to be a more sensitive measure of cardiac dysfunction.[25](#jah32936-bib-0025){ref-type="ref"} Because GLS measures the shortening of the longitudinal myocardial fibers located predominantly in the subendocardium,[23](#jah32936-bib-0023){ref-type="ref"} the wall layer most susceptible to ischemia,[7](#jah32936-bib-0007){ref-type="ref"} subclinical cardiac dysfunction can be detected earlier. Given extensive and consistent evidence linking clinical cardiac dysfunction to abnormal brain health,[13](#jah32936-bib-0013){ref-type="ref"}, [14](#jah32936-bib-0014){ref-type="ref"}, [26](#jah32936-bib-0026){ref-type="ref"}, [27](#jah32936-bib-0027){ref-type="ref"}, [28](#jah32936-bib-0028){ref-type="ref"}, [29](#jah32936-bib-0029){ref-type="ref"} future research examining cardiac function in relation to cognitive impairment and dementia risk should utilize GLS rather than or in addition to LVEF. By doing so, prevention research can be advanced by understanding how the earliest changes in cardiac dysfunction captured by GLS affect the aging brain.

The mechanisms accounting for associations between subclinical cardiac dysfunction and neuropsychological performances remain elusive but are likely multifactorial. Previous research has demonstrated an association between compromised GLS and altered cardiac hemodynamics, such as decreased stroke volume.[30](#jah32936-bib-0030){ref-type="ref"}, [31](#jah32936-bib-0031){ref-type="ref"} Despite autoregulatory mechanisms in place to preserve cerebral blood flow (CBF) in the presence of systemic blood flow reductions, animal research suggests that manipulating cardiac output (ie, stroke volume×heart rate) can have a direct impact on CBF.[32](#jah32936-bib-0032){ref-type="ref"} Furthermore, among macaque monkeys, blood flow in brain regions with tissue damage is vulnerable to the effects of systemic blood flow changes.[33](#jah32936-bib-0033){ref-type="ref"} Autoregulatory mechanisms have also been shown to be less effective in clinical samples with end‐stage heart failure,[29](#jah32936-bib-0029){ref-type="ref"} an observation that was recently reported for the first time in older adults without heart failure.[34](#jah32936-bib-0034){ref-type="ref"} Such decreases in CBF could affect brain health through multiple pathways. First, subclinical reductions in CBF can result in oligemia or mild reductions in regional CBF. Oligemia can affect protein synthesis required for synaptic plasticity associated with learning and memory.[35](#jah32936-bib-0035){ref-type="ref"}, [36](#jah32936-bib-0036){ref-type="ref"} In addition, the temporal lobes appear especially vulnerable to CBF reductions possibly due to a less extensive network of collateral blood flow sources.[37](#jah32936-bib-0037){ref-type="ref"} Second, as CBF decreases, adherens and tight junctions in the blood--brain barrier are disrupted, resulting in increased diffusion of lipid‐soluble proteins across capillary walls. Subsequently, blood‐derived neurotoxic proteins accumulate in the brain resulting in suppressed capillary blood flow and neurodegeneration.[38](#jah32936-bib-0038){ref-type="ref"}, [39](#jah32936-bib-0039){ref-type="ref"} Such changes can be exacerbated in older adults as blood--brain barrier breakdown has been reported in the hippocampus with normal aging.[38](#jah32936-bib-0038){ref-type="ref"} The increased vulnerability of the hippocampus aligns with the memory and learning results observed in this study, not only with the memory composite but also with the individual verbal and nonverbal visuospatial learning and retention measures. The present findings support such anatomical vulnerability given that only learning, memory, and language performances were affected, all of which are cognitive functions localized to the temporal lobe.[40](#jah32936-bib-0040){ref-type="ref"}, [41](#jah32936-bib-0041){ref-type="ref"} Furthermore, the anatomical vulnerability of the temporal lobes may explain why cognitive associations reported in this study did not include executive functions (as initially hypothesized), such as planning, sequencing, generation, and inhibition behaviors facilitated by the frontal lobes and frontal--subcortical circuitry.

An alternative mechanism underlying the current findings may be related to the geometry of the left ventricle. Increased LV mass is associated with compromised GLS,[42](#jah32936-bib-0042){ref-type="ref"} worse cognition,[43](#jah32936-bib-0043){ref-type="ref"} and increased stroke risk.[44](#jah32936-bib-0044){ref-type="ref"} Furthermore, longitudinal shortening can be impaired in hypertensive remodeling even without overt LV hypertrophy.[45](#jah32936-bib-0045){ref-type="ref"} In response to pressure overload, as seen in aging with increased prevalence of hypertension,[46](#jah32936-bib-0046){ref-type="ref"} the ventricular wall thickens to normalize wall stress.[45](#jah32936-bib-0045){ref-type="ref"} As this process occurs, LVEF remains unaffected while myocardial shortening decreases.[47](#jah32936-bib-0047){ref-type="ref"} Before an increase in ventricular volume and onset of LV hypertrophy, the chamber volume can decrease, resulting in lower stroke volume[47](#jah32936-bib-0047){ref-type="ref"} and subsequently decreased CBF, as described earlier. Future research is needed to better understand this potential pathway.

An observation from the current study that warrants brief discussion is the counterintuitive association between LVEF and D‐KEFS Number Sequencing observed in both fully adjusted and raw unadjusted models. To better understand this finding, we examined interaction terms between LVEF and age, sex, education, race/ethnicity, FSRP minus age, and *APOE\*ε4*, all of which were not significant. Exploratory stratified analyses suggested the counterintuitive finding may be most prominent in participants who were *APOE\*ε4* negative, were male, were younger, were less educated, and had lower FSRP scores. It is plausible that the ambiguous observation may be due to a more complex multivariable interaction or confound not captured by our methods. Replication is needed to better understand this unexpected result.

Our study has several strengths. First, we used CMR, a reliable imaging technique for quantifying both LVEF and GLS. Second, because GLS is unaffected by preload and diastolic abnormalities, it provides a more reliable measure of subclinical cardiac dysfunction in comparison to LVEF. Additional strengths include utilization of a comprehensive neuropsychological protocol capturing a diverse range of cognitive outcomes across domains, comprehensive ascertainment of potential confounders, stringent quality control procedures, and utilization of a core laboratory for processing CMR measurements in which technicians were clinically blinded.

Despite these strengths, a few limitations should be considered when interpreting the current observations. First, the results are cross‐sectional and cannot speak to causality. Longitudinal studies are needed to understand the temporal nature of the associations reported and to rule out potential confounding or concomitant variables unaccounted for in our analytical models. Second, our sample included predominantly white, well‐educated, and healthy older adults (with only 3% prevalent CVD compared with 24--35% in the general population of older adults).[48](#jah32936-bib-0048){ref-type="ref"} Generalizability to other races, ethnicities, ages, or adults with poorer health is unknown. Multiple comparisons were made, raising the possibility of a false‐positive finding. We speculate that in a less healthy cohort with more vascular risk factor burden or more compromised cardiac function, the associations reported in this study would likely be stronger. Nevertheless, our results require replication, including testing associations in a less healthy cohort, because we cannot rule out the possibility of a false‐positive finding. We also cannot rule out the possibility of residual confounding.

Among older adults free of clinical stroke, dementia, and heart failure, subtle cardiac dysfunction as captured by strain relates to worse episodic memory and language performance. Using comprehensive and sensitive CMR methods to quantify cardiac function, these associations were statistically independent of key covariates, including vascular risk factors, prevalent CVD, and atrial fibrillation. Further investigation into mechanisms linking cardiac strain and abnormal brain changes with age are warranted to identify primary prevention targets or therapeutic interventions.
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